Sanofi (SNY) Other Non-Current Liabilities (2009 - 2026)

Sanofi has disclosed Other Non-Current Liabilities across 18 years of filings, most recently posting $19.1 billion for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities rose 23.29% year-over-year to $19.1 billion; the TTM figure through Jun 2026 stood at $19.1 billion (up 23.29% YoY), while the FY2025 annual figure was $18.1 billion, up 17.55% from the prior year.
• Other Non-Current Liabilities came in at $19.1 billion for Q2 2026 at Sanofi, up from $18.1 billion in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $19.1 billion in Q2 2026 to a low of $12.3 billion in Q4 2022.
• Average Other Non-Current Liabilities over 5 years is $14.9 billion, with a median of $14.8 billion recorded in 2023.
• Year-over-year, Other Non-Current Liabilities declined 4.42% in 2022 and grew 23.29% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $12.3 billion in 2022, then grew by 20.55% to $14.8 billion in 2023, then gained by 2.93% to $15.2 billion in 2024, then grew by 19.06% to $18.1 billion in 2025, then grew by 5.51% to $19.1 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $19.1 billion in Q2 2026, $18.1 billion in Q4 2025, and $15.5 billion in Q2 2025.